What Harmony Biosciences Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 7 | 13 |
| Total trades | 15 | 43 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 61,406 | 169,644 |
| Disposed | 72,406 | 178,526 |
| Net activity | −11,000 | −8,882 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 18 | Disclosed 10b5-1 sale · S | −35,852 | $43.05 | −$1.54M | 13,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 18 | Exercise / conversion · M | +25,446 | $30.27 | +$770K | 48,967 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 18 | Exercise / conversion · M | +10,406 | $30.69 | +$319K | 23,521 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 17 | Disclosed 10b5-1 sale · S | −800 | $43.00 | −$34.4K | 13,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 17 | Exercise / conversion · M | +400 | $30.27 | +$12.1K | 13,915 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 17 | Exercise / conversion · M | +400 | $30.69 | +$12.3K | 13,515 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 16 | Disclosed 10b5-1 sale · S | −1,800 | $43.01 | −$77.4K | 13,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 16 | Exercise / conversion · M | +900 | $30.27 | +$27.2K | 14,915 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 16 | Exercise / conversion · M | +900 | $30.69 | +$27.6K | 14,015 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 08 | Disclosed 10b5-1 sale · S | −22,954 | $43.10 | −$989K | 13,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 08 | Exercise / conversion · M | +10,754 | $30.27 | +$326K | 36,069 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 08 | Exercise / conversion · M | +12,200 | $30.69 | +$374K | 25,315 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 08 | Disclosed 10b5-1 sale · S | −1,000 | $42.79 | −$42.8K | 13,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 08 | Disclosed 10b5-1 sale · S | −4,500 | $42.25 | −$190K | 14,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sep 04 | Disclosed 10b5-1 sale · S | −5,500 | $41.98 | −$231K | 18,615 |
| Budur Kumar | CHIEF MEDICAL OFFICER | May 01 | Withheld — tax / exercise cost · F | −8,882 | $31.83 | −$283K | 24,115 |
| Budur Kumar | CHIEF MEDICAL OFFICER | May 01 | Exercise / conversion · M | +18,750 | — | — | 32,997 |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Apr 07 | Withheld — tax / exercise cost · F | −3,173 | $27.62 | −$87.6K | 4,327 |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Apr 07 | Exercise / conversion · M | +7,500 | — | — | 7,500 |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | Jan 26 | Disclosed 10b5-1 sale · S | −3,746 | $37.15 | −$139K | 24,521 |
Loading...